Plunkett Research Online: Eyegate Pharmaceuticals Inc

EYEGATE PHARMACEUTICALS INC (EYEG:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biotechnology company.....

Eyegate Pharmaceuticals Inc
Ticker: EYEG
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 781 788-9043
Address: 271 Waverley Oaks Road
Suite 108
Waltham, MA 02452 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing
Contacts Description

Stephen From CEO/Director/President
Sarah Romano CFO/Chief Accounting Officer
See More
A biotechnology company.....See More See More

Auditor: EisnerAmper LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: